In terms of tissue invasion and distant metastasis, TAMs enhance the invasiveness and migratory capacity of tumor cells by activating the EMT, particularly through the activation of toll-like receptor-4 and the subsequent secretion of cytokines such as IL-6 and TNF-α. This evidence concerns the gene IL6 and neoplasm.